A proven track record in the formulation development of ‘tough to crack molecules’ for liquid orals which include oral solutions, suspensions. Our expertise lies in the perfect blend of scientific acumen and pharmaceutical art in developing taste masked solutions for bitter tasting APIs, solubility enhancement, stabilization of a wide variety of drugs. Our specialty includes development and optimization of age appropriate formulations of bitter drugs using ‘e-Tongue’ technology.
We offer a complete spectrum of support from pre-clinical studies through clinical phase I-III to commercial manufacturing in our state-of-the art facilities that are approved by US FDA, MHRA and WHO. Most of the manufacturing facilities follow paperless electronic BMR systems and comply to stringent regulatory requirements.
A wide range of batch sizes can be manufactured like 50 mL to 6 L at R&D and up to 300 L at commercial manufacturing site.
Formulation development and manufacture of taste masked oral solutions for pediatric and geriatric population.
Formulation development and manufacture oral emulsions for enhanced solubility/bioavailability.
Expertise in the aqueous or non-aqueous formulation development of poorly soluble and unstable drugs
Services across the product lifecycle
US FDA inspected lab and manufacturing facilities
Experience with advanced formulation technologies
20+ years of experience in formulation
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.